Viagra, Cialis May Help Reduce Alzheimer's Risk
By Ernie Mundell HealthDay Reporter
THURSDAY, Feb. 8, 2023 -- Could drugs that give a boost to men's sexual performance help them stave off Alzheimer's disease?
That's the main finding from a study suggesting that erectile dysfunction meds like Cialis, Levitra and Viagra might lower the odds for the memory-robbing illness.
The study wasn't designed to prove cause-and-effect, cautioned British researchers at University College London.
“More research is needed to confirm these findings, learn more about the potential benefits and mechanisms of these drugs and look into the optimal dosage,” explained study co-author Ruth Brauer, a lecturer in pharmacoepidemiology and medication safety at the university.
She also believes that, “a randomized, controlled trial with both male and female participants is warranted to determine whether these findings would apply to women as well.”
The findings were published Feb. 7 in the journal Neurology.
Erectile dysfunction medications work by dilating blood vessels and increasing blood flow.
The new study involved almost 270,000 men, averaging 59 years of age, who had all been newly diagnosed with erectile dysfunction (ED). A little more than half of them were prescribed an ED drug. None of the men had any cognitive or memory issues when they entered the study.
Over five years of follow-up, 1,119 of the men were diagnosed with Alzheimer's disease.
Bauer's team reported that men who were taking an ED drug had an 18% lower odds of developing Alzheimer's compared to those who weren't. That finding held even after the researchers had adjusted for other risk factors, such as age, smoking status and alcohol consumption.
The jury is still out on whether the ED meds directly caused the drop in Alzheimer's risk, and more study is needed. But Bauer believes the research points in interesting directions.
“Although we’re making progress with the new treatments for Alzheimer’s disease that work to clear amyloid plaques in the brain for people with early stages of the disease, we desperately need treatments that can prevent or delay the development of Alzheimer’s disease,” she said in a journal news release. “These results are encouraging and warrant further research.”
Sources
- American Neurological Association, news release, Feb. 7, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
Scientists May Have Located Your Brain's 'Neural Compass'
TUESDAY, May 7, 2024 -- Researchers say they’ve identified a human “neural compass” -- a pattern of brain activity that helps prevent humans from becoming...
Gene Discovery Points to a New Form of Alzheimer's
TUESDAY, May 7, 2024 -- People who carry two copies of the gene mutation most strongly implicated in Alzheimer’s disease are almost certain to develop brain changes related...
Medicare Warnings Stop Nursing Homes From Overusing Antipsychotic Meds
FRIDAY, April 25, 2024 -- Warning letters sent by Medicare officials can prompt a decline in antipsychotic prescriptions for seniors with dementia, a new study finds. Letters...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
